Go Pro

NEXGEL (NXGLW) Competitors

NEXGEL logo
$0.02 +0.01 (+33.55%)
As of 08/3/2026 10:14 AM Eastern
This is a fair market value price provided by Massive. Learn more.

NXGLW vs. DRTSW, ANZUW, HSCSW, BEATW, and LUCYW

Should you buy NEXGEL stock or one of its competitors? MarketBeat compares NEXGEL with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NEXGEL include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW).

How does NEXGEL compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and NEXGEL (NASDAQ:NXGLW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
NEXGEL$11.27MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
NEXGEL N/A N/A N/A

In the previous week, Alpha Tau Medical had 1 more articles in the media than NEXGEL. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for NEXGEL. Alpha Tau Medical's average media sentiment score of 1.14 beat NEXGEL's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Tau Medical Positive
NEXGEL Neutral

Summary

Alpha Tau Medical beats NEXGEL on 2 of the 3 factors compared between the two stocks.

How does NEXGEL compare to Anzu Special Acquisition Corp I?

NEXGEL (NASDAQ:NXGLW) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are related companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

In the previous week, NEXGEL's average media sentiment score of 0.00 equaled Anzu Special Acquisition Corp I'saverage media sentiment score.

Company Overall Sentiment
NEXGEL Neutral
Anzu Special Acquisition Corp I Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.27MN/AN/AN/AN/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

Summary

NEXGEL beats Anzu Special Acquisition Corp I on 1 of the 1 factors compared between the two stocks.

How does NEXGEL compare to Heart Test Laboratories?

NEXGEL (NASDAQ:NXGLW) and Heart Test Laboratories (NASDAQ:HSCSW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

In the previous week, NEXGEL's average media sentiment score of 0.00 equaled Heart Test Laboratories'average media sentiment score.

Company Overall Sentiment
NEXGEL Neutral
Heart Test Laboratories Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.27MN/AN/AN/AN/A
Heart Test Laboratories$4.32KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
Heart Test Laboratories N/A N/A N/A

Summary

NEXGEL beats Heart Test Laboratories on 1 of the 1 factors compared between the two stocks.

How does NEXGEL compare to HeartBeam?

NEXGEL (NASDAQ:NXGLW) and HeartBeam (NASDAQ:BEATW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
HeartBeam N/A N/A N/A

In the previous week, NEXGEL's average media sentiment score of 0.00 equaled HeartBeam'saverage media sentiment score.

Company Overall Sentiment
NEXGEL Neutral
HeartBeam Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.27MN/AN/AN/AN/A
HeartBeamN/AN/AN/AN/AN/A

Summary

NEXGEL beats HeartBeam on 1 of the 1 factors compared between the two stocks.

How does NEXGEL compare to Innovative Eyewear?

NEXGEL (NASDAQ:NXGLW) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

In the previous week, NEXGEL's average media sentiment score of 0.00 equaled Innovative Eyewear'saverage media sentiment score.

Company Overall Sentiment
NEXGEL Neutral
Innovative Eyewear Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.27MN/AN/AN/AN/A
Innovative Eyewear$2.98MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
Innovative Eyewear N/A N/A N/A

Summary

NEXGEL beats Innovative Eyewear on 1 of the 1 factors compared between the two stocks.

Get NEXGEL News Delivered to You Automatically

Sign up to receive the latest news and ratings for NXGLW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXGLW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NXGLW vs. The Competition

MetricNEXGELHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$5.66B$6.86B$12.44B
Dividend YieldN/A1.78%2.60%10.03%
P/E RatioN/A23.65280.7424.99
Price / SalesN/A58.66588.1690.43
Price / CashN/A32.5328.6434.82
Price / BookN/A6.5111.026.21
Net IncomeN/A$151.15M$3.48B$347.49M
7 Day PerformanceN/A3.10%0.81%1.29%
1 Month PerformanceN/A-1.09%-4.15%-3.59%
1 Year PerformanceN/A3.48%61.47%18.38%

NEXGEL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NXGLW
NEXGEL
N/A$0.02
+33.6%
N/A-93.9%$0.00$11.27MN/A10
DRTSW
Alpha Tau Medical
N/A$2.68
+16.8%
N/A+1,102.5%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.03
-13.9%
N/A-34.2%$0.00N/AN/A2
HSCSW
Heart Test Laboratories
N/A$0.06
+53.8%
N/A-34.3%$0.00$4.32KN/A10
BEATW
HeartBeam
N/A$0.02
+11.2%
N/A-93.7%$0.00N/AN/A5

Related Companies and Tools


This page (NASDAQ:NXGLW) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners